SpectronRx Raises $85M From OrbiMed to Expand Isotope Production

Deal Summary

SpectronRx announced a $85 million fundraising round backed by OrbiMed to expand its isotope production and manufacturing capacity at the Grissom Aeroplex campus in Indiana. The new capital will support the company's growth and scaling of its operations.